188 related articles for article (PubMed ID: 19653048)
21. CD24 and S100A4 expression in resectable pancreatic cancers with earlier disease recurrence and poor survival.
Lee SH; Kim H; Hwang JH; Shin E; Lee HS; Hwang DW; Cho JY; Yoon YS; Han HS; Cha BH
Pancreas; 2014 Apr; 43(3):380-8. PubMed ID: 24622067
[TBL] [Abstract][Full Text] [Related]
22. The expression of S100A4 in human pancreatic cancer is associated with invasion.
Tsukamoto N; Egawa S; Akada M; Abe K; Saiki Y; Kaneko N; Yokoyama S; Shima K; Yamamura A; Motoi F; Abe H; Hayashi H; Ishida K; Moriya T; Tabata T; Kondo E; Kanai N; Gu Z; Sunamura M; Unno M; Horii A
Pancreas; 2013 Aug; 42(6):1027-33. PubMed ID: 23851436
[TBL] [Abstract][Full Text] [Related]
23. High expression of HIF1a is a predictor of clinical outcome in patients with pancreatic ductal adenocarcinomas and correlated to PDGFA, VEGF, and bFGF.
Hoffmann AC; Mori R; Vallbohmer D; Brabender J; Klein E; Drebber U; Baldus SE; Cooc J; Azuma M; Metzger R; Hoelscher AH; Danenberg KD; Prenzel KL; Danenberg PV
Neoplasia; 2008 Jul; 10(7):674-9. PubMed ID: 18592007
[TBL] [Abstract][Full Text] [Related]
24. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
[TBL] [Abstract][Full Text] [Related]
25. LMO2 is a novel predictive marker for a better prognosis in pancreatic cancer.
Nakata K; Ohuchida K; Nagai E; Hayashi A; Miyasaka Y; Kayashima T; Yu J; Aishima S; Oda Y; Mizumoto K; Tanaka M; Tsuneyoshi M
Neoplasia; 2009 Jul; 11(7):712-9. PubMed ID: 19568416
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological and prognostic significance of MUC13 and AGR2 expression in intraductal papillary mucinous neoplasms of the pancreas.
Mito K; Saito M; Morita K; Maetani I; Sata N; Mieno M; Fukushima N
Pancreatology; 2018 Jun; 18(4):407-412. PubMed ID: 29650332
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
[TBL] [Abstract][Full Text] [Related]
28. KIAA1199/CEMIP/HYBID overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma.
Koga A; Sato N; Kohi S; Yabuki K; Cheng XB; Hisaoka M; Hirata K
Pancreatology; 2017; 17(1):115-122. PubMed ID: 28012880
[TBL] [Abstract][Full Text] [Related]
29. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
[TBL] [Abstract][Full Text] [Related]
30. Value of adding GNAS testing to pancreatic cyst fluid KRAS and carcinoembryonic antigen analysis for the diagnosis of intraductal papillary mucinous neoplasms.
Kadayifci A; Atar M; Wang JL; Forcione DG; Casey BW; Pitman MB; Brugge WR
Dig Endosc; 2017 Jan; 29(1):111-117. PubMed ID: 27514845
[TBL] [Abstract][Full Text] [Related]
31. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
32. EZH2 is associated with malignant behavior in pancreatic IPMN via p27Kip1 downregulation.
Kuroki H; Hayashi H; Okabe H; Hashimoto D; Takamori H; Nakahara O; Nakagawa S; Fukushima Y; Chikamoto A; Beppu T; Hirota M; Iyama K; Baba H
PLoS One; 2014; 9(8):e100904. PubMed ID: 25084021
[TBL] [Abstract][Full Text] [Related]
33. Mutational Patterns in Pancreatic Juice of Intraductal Papillary Mucinous Neoplasms and Concomitant Pancreatic Cancer.
Takano S; Fukasawa M; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Kawakami S; Hayakawa H; Maekawa S; Mochizuki K; Kawaida H; Kono H; Itakura J; Sato T; Ichikawa D; Enomoto N
Pancreas; 2019 Sep; 48(8):1032-1040. PubMed ID: 31404021
[TBL] [Abstract][Full Text] [Related]
34. Epithelial-to-mesenchymal transition (EMT) in intraductal papillary mucinous neoplasm (IPMN) is associated with high tumor grade and adverse outcomes.
Lahat G; Lubezky N; Loewenstein S; Nizri E; Gan S; Pasmanik-Chor M; Hayman L; Barazowsky E; Ben-Haim M; Klausner JM
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S750-7. PubMed ID: 25069861
[TBL] [Abstract][Full Text] [Related]
35. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer.
Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS
J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681
[TBL] [Abstract][Full Text] [Related]
36. Elevated expression level of microRNA-196a is predictive of intestinal-type intraductal papillary mucinous neoplasm of the pancreas.
Aso T; Ohtsuka T; Tamura K; Ideno N; Kono H; Nagayoshi Y; Ohuchida K; Ueda J; Takahata S; Shindo K; Aishima S; Oda Y; Mizumoto K; Tanaka M
Pancreas; 2014 Apr; 43(3):361-6. PubMed ID: 24622064
[TBL] [Abstract][Full Text] [Related]
37. GNAS mutation is a frequent event in pancreatic intraductal papillary mucinous neoplasms and associated adenocarcinomas.
Hosoda W; Sasaki E; Murakami Y; Yamao K; Shimizu Y; Yatabe Y
Virchows Arch; 2015 Jun; 466(6):665-74. PubMed ID: 25796395
[TBL] [Abstract][Full Text] [Related]
38. Expression of mesothelin mRNA in pure pancreatic juice from patients with pancreatic carcinoma, intraductal papillary mucinous neoplasm of the pancreas, and chronic pancreatitis.
Watanabe H; Okada G; Ohtsubo K; Yamaguchi Y; Mouri H; Motoo Y; Wakabayashi T; Sawabu N
Pancreas; 2005 May; 30(4):349-54. PubMed ID: 15841046
[TBL] [Abstract][Full Text] [Related]
39. Increased CDC20 expression is associated with pancreatic ductal adenocarcinoma differentiation and progression.
Chang DZ; Ma Y; Ji B; Liu Y; Hwu P; Abbruzzese JL; Logsdon C; Wang H
J Hematol Oncol; 2012 Apr; 5():15. PubMed ID: 22475564
[TBL] [Abstract][Full Text] [Related]
40. Reg proteins promote acinar-to-ductal metaplasia and act as novel diagnostic and prognostic markers in pancreatic ductal adenocarcinoma.
Li Q; Wang H; Zogopoulos G; Shao Q; Dong K; Lv F; Nwilati K; Gui XY; Cuggia A; Liu JL; Gao ZH
Oncotarget; 2016 Nov; 7(47):77838-77853. PubMed ID: 27788482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
